ESMO expert consensus statements (ECS) on the definition, diagnosis, and management of HER2-low breast cancerP. Tarantino, G. Curigliano, Giulia Viale et al.|Annals of Oncology|2023Cited by 298
Outcome of special types of luminal breast cancerMarco Colleoni, Giulia Viale, Nicole Rotmensz et al.|Annals of Oncology|2011Cited by 123
Cell Reprogramming Requires Silencing of a Core Subset of Polycomb TargetsGiulia Fragola, Giuseppe Testa, Pierre‐Luc Germain et al.|PLoS Genetics|2013Cited by 68
Impact of systemic and tumor lipid metabolism on everolimus efficacy in advanced pancreatic neuroendocrine tumors (pNETs)Claudio Vernieri, Filippo de Braud, Sara Pusceddu et al.|International Journal of Cancer|2018Cited by 65
Immune and gene-expression profiling in estrogen receptor low and negative early breast cancerDavide Massa, Maria Vittoria Dieci, Claudio Vernieri et al.|JNCI Journal of the National Cancer Institute|2024Cited by 32